Virus Eradication- Articles

issn: 2055-66-40 - print

issn 2055-66-59 - online

issn: 2055-66-40 - print

issn 2055-66-59 - online

Issue 3.1

CDC

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation

Jonathan Liu, Pedro Goicochea, Timothy Block, Carol L Brosgart, Eric F Donaldson, Oliver Lenz, Seng Gee Lim, Ed G Marins, Poonam Mishra, Marion G Peters, Veronica Miller

CDC

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection

Suha Saleh, Lenard Vranckx, Rik Gijsbers, Frauke Christ, Zeger Debyser

NIAID

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients

Maura Manion, Bruno B Andrade, Rebecca DerSimonian, Wenjuan Gu, Adam Rupert, Laura W Musselwhite, Juan G Sierra-Madero, Pablo F Belaunzaran-Zamudio, Ian Sanne, Michael M Lederman, Irini Sereti

NIAID

Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women

W van Snippenburg , FJB Nellen , C Smit , AMJ Wensing , MH Godfried , T Mudrikova

Cienpies Design/123RF Stock Photo

Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US

Karine Dubé, David Evans, Laurie Sylla, Jeff Taylor, Bryan J Weiner, Asheley Skinner, Harsha Thirumurthy, Joseph D Tucker, Stuart Rennie, Sandra B Greene

NIAID

Demographic and clinical correlates of HIV-1 RNA levels in antiretroviral therapy-naive adults attending a tertiary hospital in Jos, Nigeria

Joseph Anejo-Okopi, Isaac Okoh Abah , Yakhat Barshep, Augustine Odo Ebonyi , Comfort Daniyam, Samson Ejiji Isa, Gomerep Simji, Stephen Oguche, Patricia Agaba, Oche Agbaji , John A Idoko, Patricia Lar

NIAID

Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells

Zhe Yuan, Guobin Kang, Wuxun Lu, Qingsheng Li

NIAID

HIV Reservoir Characterization Symposium, 19 September 2016, Ghent, Belgium

Eva Malatinkova, Ward De Spiegelaere, Linos Vandekerckhove, Magdalena Sips

NIAID

Highlights from the Third Biennial Strategies for an HIV Cure Meeting, 14–16 November 2016, Bethesda, MD, USA

Diane Lawrence, Lillian Kuo, Elizabeth Church, Betty Poon, Stephen Smiley, Brigitte Sanders-Beer, Liza Dawson, Karl Salzwedel

Displaying 1 to 9 (of 9 articles)

[Show 6 per page]

issn: 2055-66-40 - print

issn 2055-66-59 - online

issn: 2055-66-40 - print

issn 2055-66-59 - online

Subject

Issues

Issue 3.1

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients

Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women

Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US

Demographic and clinical correlates of HIV-1 RNA levels in antiretroviral therapy-naive adults attending a tertiary hospital in Jos, Nigeria

Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells

HIV Reservoir Characterization Symposium, 19 September 2016, Ghent, Belgium

Highlights from the Third Biennial Strategies for an HIV Cure Meeting, 14–16 November 2016, Bethesda, MD, USA

Article Type

Subject

Issues

Issue 3.1

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients

Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women

Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US

Demographic and clinical correlates of HIV-1 RNA levels in antiretroviral therapy-naive adults attending a tertiary hospital in Jos, Nigeria

Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells

HIV Reservoir Characterization Symposium, 19 September 2016, Ghent, Belgium

Highlights from the Third Biennial Strategies for an HIV Cure Meeting, 14–16 November 2016, Bethesda, MD, USA